Bill Of Health

OCTOBER 27, 2023

The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.

Biotechnology 64

Biotechnology Regulations Medical Services Health Data 64

Bill Of Health

MAY 20, 2024

The EU’s AI Act sets rigorous standards for high-risk AI systems, emphasizing robust data quality, detailed record-keeping, and clear user information to ensure transparency and accountability. These reforms streamline liability claims and establish clearer accountability for AI-generated issues.

Regulations 45

Regulations Healthcare Biotechnology Accountability 45

Bill Of Health

APRIL 8, 2025

State Regulation of AI While states typically turn to traditional tort law to regulate medical technologies, states may turn to Corporate Practice of Medicine Doctrine (CPOM) to regulate AI use in health care. Her research interests include genetics, environmental health sciences, novel biotechnologies, and the FDA regulatory process.

Regulations 52

Regulations Biotechnology Health Science Medical Technology 52